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1. Introduction 
All measurements, regardless of their purpose, context or quality, possess uncertainty. No 
measurement is performed with absolute perfection since all are approximations. 
Uncertainty, however, does not mean there is anything wrong or inappropriate with the 
results. Uncertainty is simply a measure of the confidence we have in our best estimate and 
results from limitations in our technology, our methods, our standards and our limited 
understanding of the property being measured. [Drosg] Uncertainty is a fundamental 
property of the natural world in which we live and work. Moreover, no measurement is 
fully interpretable within a given context until the full process generating the result is 
understood. The general additive measurement function observed in equation 1 illustrates 
this basic limitation of all measurements: 
 Y       (1) 
where: Y = the measurement result 
µ = the true value of the measurand 
ǃ = measurement error due to bias 
ε = random measurement error 
Our measurement is an imperfect representation of the measurand due to bias and random 
error components. Bias may be corrected for when reliably determined with traceable 
controls. Random error, on the other hand, cannot be corrected for but can be minimized to 
an acceptable level. Figure 1 illustrates how these two contributors to uncertainty influence 
measurement results - where we have assumed a normal distribution. Bias is simply the 
difference between the mean and the reference value while random error, determined by the 
variance or standard deviation, defines the width of the distribution. Figure 1 also illustrates 
another important property of measurement - all results are random variables that arise 
from a specified distribution. As a result they have a fixed mean and variance from which 
confidence intervals can be determined – an useful metric for defining uncertainty. The fact 
that uncertainty exists in our measurements, however, should not alarm us. We simply need 
to understand it, acknowledge it, estimate it in a statistically valid way, report it and ensure 
that it is fit-for-purpose. 
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Fig. 1. Measurement results, Y, are random representations from a distribution having a 
fixed mean and variance. The variance defines the random error while the mean relative to a 
reference defines their bias 
Forensic toxicologists have a conceptual understanding of measurement uncertainty. 
However, most would probably find it difficult to actually compute a statistically valid 
estimate of the uncertainty, accounting for all relevant factors, and report it in an intuitive 
and comprehendible fashion for a jury to understand. For most analytical measurements 
performed by forensic toxicologists, both quantitative and qualitative, the formalization of 
measurement uncertainty is not generally considered or provided. This is due, in large part, 
to the lack of customer demand. The primary customers of forensic toxicologists are the 
courts and members of the legal community. They do not understand measurement 
uncertainty and are not aware of its relevance or importance. This, however, is changing. 
The legal community is becoming more aware of the concept  and is now demanding it in 
several jurisdictions. The uncertainty allows the user to judge the quality and validity of the 
measurement results for a given application. Several factors have contributed to this 
renewed interest in measurement uncertainty. One is a recent report from the National 
Academy of Sciences in 2009. The NAS report states, “All results for every forensic science 
method should indicate the uncertainty in the measurements that are made,...”. (NAS, 2009) 
The report was largely critical of the forensic sciences arguing the lack of a strong scientific 
foundation for their claims and practices. Another influencing factor has been the US 
Supreme Court decision in 1993 of Daubert vs. Merrell Dow Pharmaceuticals. The court 
required one of four criteria for admissibility to be “...the technique’s known or potential 
rate of error...”. (Daubert vs. Merrell Dow, 1993) The ruling requires that uncertainty be 
considered and accompany the introduction of measurement results in court. Finally, 
accrediting agencies are now requiring that forensic laboratories perform and report 
measurement uncertainty as part of their analytical protocol. The ASCLD/LAB-
International accreditation program, for example, has adopted the ISO/IEC 17025 program 
and requires in part that, “...the laboratory estimate the measurement uncertainty for any 
area of testing or calibration where the customer makes the request or the jurisdiction or 
statute requires such“. (ASCLD/LAB, 2011) These and other factors have now brought 
attention on this issue to measurement uncertainty. Forensic toxicologists need to address 
the issue and be prepared to compute, report and explain measurement uncertainty. 
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Moreover, providing the uncertainty along with measurement results is one important step 
in ensuring evidence-based inference. (Mnookin, et.al., 2011) We intend to illustrate and 
explain here several practical ways this can be accomplished.  
Very basically, measurement uncertainty is best described by an interval, symmetric about 
the measurement result and within which we claim that the true value (the measurand) 
exists with some level of probability. The end points of this interval are called uncertainty or 
confidence limits. This interval quantifies the precision of the measurement result. Figure 2 
illustrates this concept of uncertainty. The classical statistical view would state that the 
measurand (µ) is a fixed quantity and the measurement result along with the interval limits 
are random variables. The probability, therefore, relates to the random interval actually 
encompassing the fixed true value (µ). This involves some subtle distinctions between 
classical and Bayesian statistics which will not be discussed further here. Suffice it to say, 
our general approach regarding the estimation of measurement uncertainty will be classical 
in nature.  
 
 
Fig. 2. Measurement uncertainty is best viewed as an interval symmetric about the mean 
and within which we claim the measureand lies with some stated level of probability 
Not all measurement processes are capable of providing a rigorous and statistically valid 
estimate of uncertainty. This fact is acknowledged by metrologists and by the ISO 17025 
document in particular. (IEC/ISO 17025, 2000) For these situations, ISO 17025 requires that 
the analyst or laboratory at least identify the uncertainty components and make a reasonable 
effort to express the uncertainty. All of the published guides on measurement uncertainty 
recognize that every measurement context is different and there are multiple ways for 
estimation. Accordingly, forensic toxicologists should develop a well reasoned documented 
approach that can be justified to both the legal and accrediting communities.  
Consider the following two separate blood alcohol concentrations measured on samples 
from two different individuals: 0.086 g/dL, 0.104 g/dL. Which result presents the stronger 
inference that the subject’s true blood alcohol concentration exceeds 0.080 g/dL? Very 
simply, we do not know. We have no information regarding the measurement process or the 
uncertainty for each. Now consider the same two results along with their two standard 
deviation uncertainty estimates: 0.086 ± 0.005 g/dL, 0.104 ± 0.027 g/dL. From this we now see 
that the first results (0.086 ± 0.005 g/dL) provide the stronger evidence that the individual’s 
true blood alcohol concentration exceeds 0.080 g/dL. Figure 3 illustrates this as well. The 
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result of 0.104 g/dL actually has a significant probability that the true value is below 0.080 
g/dL. This illustrates the additional value provided by measurement uncertainty, 
particularly in the cases near critical prohibited limits. Such information would be important 
for a court to consider. 
 
 
Fig. 3. Including measurement uncertainty adds considerable information when interpreting 
measurement results near critical concentrations 
1.1 The meaning of Fit-for-purpose 
Fitness-for-purpose (FFP) is a very important concept in analytical measurements designed 
to be used in important decision making contexts. FFP is the assurance that a measurement 
result will be suitable or appropriate for its intended applications. FFP is closely associated 
with uncertainty and the confidence that is necessary for a measurement result in a 
particular application. Measurement results in forensic toxicology have significant 
implications for the rights and property of individuals. Major consequences result from their 
interpretation in a legal context. For this reason, measurement results generated by forensic 
toxicologists must have a high level of confidence with minimum uncertainty to ensure their 
FFP. Determining the FFP in forensic toxicology can be challenging. (Thompson and Fearn, 
1996) Toxicologists and customers should both contribute to establishing the appropriate 
FFP in a forensic context. Forensic toxicologists should continually strive to optimize their 
process and enhance the quality.  
1.2 Published resources 
There are a few important resource documents regarding measurement uncertainty that 
should be read and kept as references by the forensic toxicologist. These represent standards 
in the field of metrology. They are rigorous and well grounded theoretically. However, this 
does not mean there is uniform acceptance of these documents. There is a great deal of 
literature debating their application and interpretation. (Bich and Harris, 2006, Deldossi and 
Zappa 2009, Kacker,et.al. 2007, Kacker,et.al. 2010, Krouwer, 2003, Kristiansen, 2003) Three 
references of significant importance are:  
1. Guide to the Expression of Uncertainty in Measurement (GUM): (ISO, 2008) This is 
commonly referred to as the GUM document and is published by ISO along with 
several other international standards organizations. The GUM provides primarily a 
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“bottom-up” approach to uncertainty estimation. They generally begin with an 
assumed measurement model and then proceed to employ the general method of error 
propagation.  
2. EURACHEM/CITAC Guide, Quantifying Uncertainty in Analytical Measurement: 
(EURACHEM/CITAC, 2000) This document is similar to the GUM and provides all of 
the basic terminology and computations. The illustrated examples are more relevant to 
chemistry and may be more helpful to toxicologists.  
3. NIST Technical Note 1297, Guidelines for Evaluating and Expressing the Uncertainty of 
NIST Measurement Results: (NIST, 1994) This document is brief but includes the key 
concepts and definitions. There are very few illustrated examples.  
All of these documents are available on the internet and can be downloaded free of charge. 
There are also a large number of other documents and guidelines regarding measurement 
uncertainty available on the internet. As one begins to read this large body of literature it 
soon becomes apparent that there is no consensus in the analytical sciences on the best 
approach to estimating measurement uncertainty.  
2. The measurement model 
The measurement model is a mathematical function where the measurement result (the 
response variable) is expressed explicitly as a function of several input (predictor) variables. 
Equation 2 shows the general form: 
  1 2, ,..., nY f X X X  (2) 
where: Y = the measurement result 
Xi = the predictor or input variables 
The values of X in equation 2 may represent quality control results, bias estimates, 
traceability components, a total measurement method component, calibrant materials, etc. 
Moreover, the values of X may themselves be functions of other input variables. The 
function f may be additive as illustrated in equation 3: 
 1 2 ... nY X X X     (3) 
For additive models with independent input variables, the uncertainty is found from the 
root sum square (RSS) of the variance terms for each component as illustrated in equation 4: 
 
1 2
2 2 2...
nY X X X
u u u u     (4) 
where: 2
iX
u  the variance estimate for the ith variable 
The function f may, on the other hand, be multiplicative as in equation 5: 
 1 2 ... nY X X X     (5) 
For the multiplicative model with independent variables the uncertainty is found by 
employing the RSS of the coefficients of variation squared as in equation 6: 
 
1 2
2 2 2...
n
Y
X X X
u
CV CV CV
Y
     (6) 
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Notice also that equation 6 incorporates the mean Y and yields the standard deviation of the 
mean. This will result when we incorporate the appropriate sample sizes (values of n) for 
each term within the radical sign of equation 6. The function f may even be a combination of 
additive and multiplicative terms as in equation 7: 
 1 2 5
3 4
X X
Y X
X X
   (7) 
In this case the uncertainty must be estimated by employing the general method of error 
propagation. The equation for this estimation is derived from the first-order (linear term) of 
the Taylor series expansion: (Ku, 1966)  
 
1 2
22 2
2 2 2
1 2
...
n
Y
X X X
n
u Y Y Y
u u u
X X XY
                     
 (8) 
Equation 8 also assumes that all of the input variables are independent. When this is not the 
case, a covariance term must be added as seen in equation 9: 
  2 2
1
2 ,
i
n
Y
X i j
i i ji
u Y Y Y
u Cov X X
X X XY 
                    
  (9) 
 where: 
   ,, i ji ji j X XX XCov X X r S S   
The value of r in equation 9 is the correlation coefficient between the two input variables. 
For each pair of input variables that are correlated an additional covariance term would 
need to be added. A simple example of a concentration measurement function that could 
apply to either blood or breath alcohol measurement is shown in equation 10: 
 0Corr
C R
C
X
  (10) 
where: CCorr = the corrected measurement concentration result 
C0 = the raw measurement results (either a mean or a single observation) 
R = the traceable reference control value 
X  the mean results from measuring the control reference standard (R) 
Since equation 10 is multiplicative and we assume all three variables are independent we 
could employ the RSS for the CV’s squared according to equation 11. Notice that we have 
incorporated the values of n, which may vary for each term, where this information is 
known. This will result in 
CorrC
u  representing the standard deviation (or standard error) of 
the mean. Equation 12 illustrates a more complicated model that may represent the 
measurement of breath alcohol concentration. Bias in the breath test instrument is adjusted 
for by measuring controls which have been measured by gas chromatography and which in 
turn has had its bias accounted for by measuring other traceable controls. 
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2
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2 2 2
0
Corr
C
X
CC XR
C R X
Corr
u u
nu nu
CV CV CV
C C R X
                             
 (11) 
  
 
0 Sol
Corr
Cont
Y GC R
Y
X K GC
     (12) 
where: 0Y  the mean of the original n measurements 
SolGC  the mean of the simulator solution measurements by gas chromatography 
R  the traceable reference value of alcohol in water solutions purchased from a 
commercial vendor 
X  the mean of the breath test instrument measuring the simulator solution heated to 340C 
K  1.23 the ratio of partition coefficients relating to the simulator heated to 340C  
ContGC   the mean results from measuring the traceable controls on the gas chromatograph 
Notice also that equation 12 is simply a set of correction factors that adjust for bias in the gas 
chromatograph as well as in the breath test instrument: 
 
0
0 0
Sol Sol
Corr Inst GC
ContCont
Y GC R GC R
Y Y Y f f
GCX K GC X K
                   
 (13) 
where: Instf  correction factor for the breath test instrument 
GCf  correction factor for the gas chromatograph 
The uncertainty estimates for R and K will generally be Type B estimates available from 
certificates of analysis or other documentation. The other four factors will be Type A 
estimates since they are based on actual experimental results. The uncertainty computation 
for equation 13 can be determined from employing either the RSS method of equation 6 
(since the function is multiplicative) or the error propagation method of equation 8. Both 
will yield the same estimate. We have illustrated only a few of the many measurement 
functions that may be relevant for forensic toxicologists. More examples are found in the 
EURACHEM/CITAC Guide as well as other literature sources. (Kristiansen and Peterson, 
2004) The important point is to try and develop a model best describing the measurement 
process which will facilitate selecting the most appropriate uncertainty computation to 
perform. Where the measurement model is unknown it is common to assume a 
multiplicative form. The justification for this is the fact that variation generally increases 
with concentration, a property of a multiplicative model. (Kristiansen, 2001) 
3. Traceability 
Traceability is defined within the VIM document as a “...property of a measurement result 
whereby the result can be related to a reference through a documented unbroken chain of 
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calibrations, each contributing to the measurement uncertainty”. (ISO/VIM, 2008) Figure 3 
illustrates this concept of traceability which links a measurement result (breath alcohol) to a 
national metrological authority with each link propagating its own uncertainty. The 
magnitude of uncertainty will increase with each additional level of the metrological chain. 
Since standards are imperfect there is the associated uncertainty that must be included as 
part of the final combined measurement uncertainty. The ultimate reference is usually a 
property maintained and defined by some metrological authority such as a National 
Metrological Institute (NMI). Chemical analytes are generally considered traceable to a 
method or standard reference material (SRM) such as NIST 1828b. There are other 
intermediate standards often used between the measurement result and the NMI. These are 
referred to as Certified Reference Materials (CRM) or simply Reference Materials (RM). 
(Thompson, 1997) Traceability is important for establishing the property of comparability 
and to determine and correct for bias. Uncertainty information regarding traceable 
standards are found on the certificates of analysis (COA).  
 
 
 
 
 
Fig. 4. Illustrating traceability where a measurement result is linked through an unbroken 
chain of comparisons to the national metrological authority  
4. Practical steps for estimating measurement uncertainty 
There are several valid approaches to estimating and quantifying measurement uncertainty. 
For our present purposes, we will present a very general “bottom-up” corresponding to the 
GUM document. Later, we will discuss other approaches as well. We will assume the 
 
u1
u2 
u3 
u4 
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following eight basic steps for estimating measurement uncertainty that should generally 
apply for most quantitative measurements in forensic toxicology: 
1.  Clearly define the property to be measured (the measurand) 
2. Identify the measurement function 
3. Identify the components contributing to the measurement uncertainty 
4. Quantify the standard uncertainty for each component 
5. Combine the standard uncertainties for each component and compute the combined 
uncertainty 
6. Compute the expanded uncertainty and the confidence interval 
7. Produce the uncertainty budget 
8. Report the results 
Next, we present these steps in some detail. In addition we will present an example of blood 
alcohol measurement by gas chromatography and illustrate how each of the steps can be 
applied. We will assume duplicate blood alcohol results of 0.081 and 0.082 g/dL for this 
example. 
4.1 Clearly define the measurand 
It is very important that the customer and the toxicologist have a clear understanding of 
exactly the property being measured. Interpretation will then be applied to a specific 
measurand in a specific context where FFP can be appropriately determined. For our 
example we will assume that the measurand is the venous whole blood alcohol 
concentration collected from a specific individual at a specific time and location.  
4.2 Identify the measurement function 
We will assume the following basic model for our measurement of blood alcohol 
concentration (BAC) by headspace gas chromatography: 
 0corr dilutor
C R
C f
X
   (14) 
where: Ccorr = the corrected BAC results 
C0 = the mean of the original measurement results 
R = the traceable reference control value 
X  the mean results from measuring the controls 
fdilutor = the correction factor for the dilutor 
Equation 14 is a basic multiplicative model that includes four components of uncertainty 
and corrects for analytical bias.  
4.3 Identify the components of uncertainty 
From equation 14 we see four components that contribute to the combined uncertainty in 
the corrected BAC. These include: (1) the original duplicate measurement results of the 
blood alcohol concentration, (2) the reference value (R) representing a traceable unbiased 
control standard purchased from a commercial laboratory having a certificate of analysis, (3) 
the mean of the replicate measurements  X  of the traceable control and (4) the correction 
factor  dilutorf  for the dilutor used in preparing both the controls and blood samples before 
analysis. We will assume 1dilutorf  .  
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4.4 Quantify the standard uncertainties for the components 
For our example we will assume the values for the four parameters are those shown in Table 
1. The uncertainty for the reference value (R) is a Type B uncertainty which comes from the 
certificate of analysis provided by the vendor preparing the control standard. The 
uncertainty for the replicate measurements of the control standard is simply the standard 
deviation determined from n=8 measurements of the control standard. The uncertainty for 
the dilutor was determined from the certificate of analysis. Since the dilutor is designed to 
provide 10 ml volume we see a small bias exists. This is not corrected for since the same bias 
would influence both the control standard measurements as well as the blood samples. For 
this reason we assume 1dilutorf  . The actual value of the dilutorf  in table 1 (10.15ml), 
however, will be used to estimate its uncertainty. The uncertainty associated with the blood 
alcohol results reported in table 1 (0.00072 g/dL) requires some further explanation. The 
uncertainty associated with these BAC results represents total method uncertainty. This 
estimate will be determined from a large number of duplicate BAC results generated within 
the same laboratory over a long period of time (approximately one year). This would 
include variation from sample preparation, multiple instruments, multiple calibrations, 
multiple analysts, multiple uses of the dilutor and time. Figure 5 illustrates an uncertainty 
function generated from duplicate blood alcohol data analyzed in the forensic laboratory of 
New Zealand. (Stowell, e.tal., 2008) For illustration purposes, we will assume this model is 
relevant to our example. Each point in the plot represents the standard deviation associated 
with a single determination and is generated from the following equation for a pooled 
estimate: 
 
2
1
2
k
i
i
B
d
u
k


 (15) 
where: uB = the standard deviation for a single measurement of blood alcohol concentration 
di = the difference between duplicate results for the ith sample 
k = the total number of duplicate samples within the bin 
Duplicate results are pooled into bins of 0.010 g/dL to generate the uncertainty estimates 
throughout the concentration range. The result is an estimate of the uncertainty as a function 
of concentration and reveals the general increase in variation with concentration. Some 
would advocate the use of a characteristic function rather than an uncertainty function. 
(Thompson and Coles, 2011) A characteristic function is generated from regressing the 
variance against the concentration squared. Before estimating our method uncertainty from 
these functions, we need to determine our corrected BAC result. This is done as follows: 
  
  
 0
0.0815 0.100
1 0.0827 /
0.0986
corr dilutor
C R
C f g dL
X
       (16) 
We now use this corrected result to estimate our method uncertainty from the model in 
figure 5. Based on the linear uncertainty function in figure 5 we obtain a method uncertainty 
of 0.00076 g/dL. Developing the characteristic function for the same data set yields a 
method uncertainty estimate of 0.00072 g/dL. Therefore, we will use the value of 0.00072 
g/dL for example, as we see in table 1.  
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Parameter Values Type 
Standard 
Uncertainty 
n 
C0 (0.082, 0.081 g/dL)0.0815 g/dL A 0.00072g/dL 2 
R 0.100 g/dL B 0.0004 g/dL 1 
X  0.0986 g/dL A 0.0008 g/dL 8 
dilutorf  10.15 ml B 0.050 ml 10 
Table 1. Estimates, standard uncertainties and the number of measurements for the four 
parameters assumed to contribute to the combined uncertainty of blood alcohol 
measurement 
 
 
Fig. 5. An uncertainty function plotting pooled standard deviation estimates against their 
concentration determined from a large number of duplicate blood alcohol results 
4.5 Combine the standard uncertainties and compute the combined uncertainty 
We first determine our combined uncertainty using the general method of error propagation 
found in equation 8 assuming independence amongst the predictor variables. Putting our 
values determined from equation 16 into equation 8 we obtain equation 17. Since our 
measurement function is multiplicative we also estimate our combined uncertainty using 
equation 6 and assuming independence we obtain equation 18. Notice that we have 
included the actual estimate for fdilutor of 10.15 ml. This will ensure the appropriate value is 
determined for the uncertainty of the dilutor component. For purposes of bias correction in 
the measurement function of equation 14, however, we assume the value of fdilutor = 1.0. 
From equations 17 and 18 we see that both the RSS method of equation 6 and the error 
propagation method of equation 8 yield nearly identical results.  
Blood Alcohol Concentration (g/100ml)
0.0 0.1 0.2 0.3 0.4 0.5
Standard Deviation (g/100ml)
0.000
0.001
0.002
0.003
0.004
0.005
SD = 0.0038BAC + 0.000447
n = 13,159 duplicates
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 (18) 
4.6 Compute the expanded uncertainty and uncertainty interval 
The expanded uncertainty is denoted by the value U and is determined from: CU ku  
where k = a coverage factor and uC = the combined uncertainty. The expanded uncertainty 
is then used to generate an uncertainty interval as  
 cY k u Y U    (19)  
where: Y  the unbiased mean measurement result, k = the coverage factor and U = the 
expanded uncertainty. Notice that Cu  is actually the standard deviation of the mean. This 
results from the fact that we included the appropriate sample sizes, where available, for 
each term in equations 17 and 18. Sample size also determines degrees of freedom and 
whether the normal distribution can be assumed or if the t-distribution should be employed. 
Sample size should be determined as part of the measurement design to ensure sufficient 
quality control and statistical power. Coverage factors of k=2 or k=3 are common and 
represent approximately 95% and 99% uncertainty intervals respectively. Selecting k=2 or 3 
assumes large degrees of freedom (sample size ≥ 30). Sample sizes less than 30 should 
employ the Students t distribution. From table 1 we see that none of the sample sizes exceed 
ten. However, we could argue that the method uncertainty associated with the duplicate 
blood alcohol results (0.00072 g/dL), determined from the data in figure 5, was generated 
from over 11,000 duplicate blood alcohol results. This should clearly justify the use of k=2 or 
3 for approximate estimates of the 95% and 99% expanded uncertainty intervals. For our 
present example, however, we will assume we have the limited number of observations 
noted in table 1 and illustrate the calculation of what is called the “effective degrees of 
freedom”, which may be necessary in some forensic contexts. For this purpose we employ 
the Welch-Satterthwaite equation which assumes the estimation of the effective degrees of 
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freedom for a probability distribution formed from several independent normal 
distributions as in equation 20. (Ballico, 2000, Kirkup and Frenkel, 2006)  
 
4
4
1
C
eff k
i
ii
u
u




  (20) 
where: veff = the effective degrees of freedom 
4
Cu  the combined uncertainty  
4
iu  the uncertainty associated with the ith component 
k = the number of components contributing to the combined uncertainty 
The uncertainty terms  4iu  can be determined either from the coefficients of variation (CV) 
or from partial derivatives determined from the measurement function in equation 14. If the 
CV estimates are used we do not incorporate the sample size n for each term. We will 
determine the CV estimates for our example. We first compute the combined uncertainty 
again as in equation 21.  
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                    
                         
 (21)  
Next, we incorporate these results into equation 20 as follows:  
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From this computation we see that the effective degrees of freedom can be some non-integer 
value, in which case the value is generally truncated. Notice also that the uncertainty 
associated with the reference value (R) has an infinite number of degrees of freedom. This is 
because it is a Type B uncertainty determined from a certificate of analysis where we 
assume the uncertainty in the uncertainty estimate (0.0004 g/dL) is zero with 
correspondingly large degrees of freedom. As a result this term disappears from the 
computation. Each of the other degrees of freedom is determined from n-1. From these 
results we would estimate our value from the t-distribution to be: 0.975, 4 2.776t   for 
estimating a 95% uncertainty interval. Using these results along with our combined 
uncertainty determined from equation 18 we would obtain a 95% uncertainty interval of: 
 0.0827 2.776 0.00067 0.0827 0.0019 0.0808 0.0846 /CY k u to g dL      .  
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We now have an interval within which we would expect a large fraction (approximately 
95%) of the expected values of the measurand to exist. If we were to assume k=2 to  
generate an approximate 95% uncertainty interval we would obtain:
 0.0827 2 0.00067 0.0827 0.0013 0.0814 0.0840 /to g dL    . We see that this interval is 
slightly narrower than that employing the effective degrees of freedom estimate. Choosing 
the appropriate coverage factor will be a decision made within each forensic laboratory. A 
99% interval (k=3) will provide a higher degree of confidence that may be important in 
forensic applications. This is particularly true where results are near prohibited legal limits. 
Whatever decision is made, the value for k should be clearly identified in the program 
policy or SOP manuals and strictly adhered to in practice. In this example we have assumed 
our expanded interval to be an “uncertainty interval” rather than a “confidence interval”. 
The GUM document prefers the term “uncertainty interval” or “level of confidence”. 
(ISO/GUM, 2008) Others, however, interpret U as representing a confidence interval which 
has a specific definition in the classical statistical sense.  
4.7 Produce the uncertainty budget 
Table 2 illustrates one form of an uncertainty budget for our example. The uncertainty 
budget lists the components contributing to the combined uncertainty along with the 
percent of their contribution to the total. The percent contributions were determined from 
the terms under the radical sign in equation 18. This is very useful for identifying which 
components are the major contributors and which may be reasonably ignored. The GUM 
document states that any contributions less than one-third of the largest contributor can be 
safely ignored. (ISO/GUM, 2008) Based on this we see that the analytical and dilutor 
components could be safely ignored in this example. However, from a forensic perspective 
it may be better to include all components considered, providing full disclosure. We see that 
the total method contributes the largest component at 59%. This is expected because of all of 
the contributing sub-components involved: analysts, calibrations, time, dilutions, etc. This 
analysis does not include, however, the venous blood sampling performed by the 
phlebotomist who typically performs only one venipuncture. Moreover, many laboratories 
do not even consider sampling as a component of their combined uncertainty. They simply 
consider their uncertainty estimates corresponding to the sample “as received in the 
laboratory”. Jones, for example, has considered sampling as a source of uncertainty in some 
of his published work. (Jones, 1989)  
 
Source  Type Distribution Standard Uncertainty Percent1 
Traceability B Normal 0.0004 g/dL 24% 
Analyical A Normal 0.0008 g/dL 13% 
Dilutor B  Normal 0.050 ml 4% 
Total Method A Normal 0.00072 g/dL 59% 
Combined Uncertainty   0.00067 g/dL  
Expanded Uncertainty 
(k=2.776) 
  0.0019 g/dL  
95% confidence interval   0.0808 to 0. 0846 g/dL  
1Percent of contribution to total combined uncertainty 
Table 2. Uncertainty budget for the illustrated example 
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4.8 Report the results 
One of the most important, yet often overlooked, elements of determining measurement 
uncertainty is reporting the results. A great deal of thought should be given to this aspect of 
measurement. The end-user should be consulted to determine exactly what is needed for 
their application. There should be sufficient information so the results and their associated 
uncertainty are fully interpretable and unequivocal for a specific application without 
reference to additional documentation. This will necessitate some textual explanation in 
addition to the numerical results. One possibility for our blood alcohol example above is: 
The duplicate whole blood alcohol results were 0.082 and 0.081 g/dL with a corrected mean result  of 
0.0827 g/dL. An expanded combined uncertainty of 0.0019 g/dL assuming a coverage factor of  
k=2.776 with an effective degrees-of-freedom of 4 and a normal distribution was generated from  four 
principle components contributing to the uncertainty. An approximate 95% confidence interval for 
the true mean blood alcohol concentration is 0.0808 to 0.0846 g/dL.  
In addition to the statement, a figure similar to that of figure 3 could be provided which 
might assist the court in placing the results in some geometric perspective. The format for 
reporting the results should be considered flexible. As time goes on there will no doubt be 
the need for revision to ensure clarity in communication and interpretation.  
4.9 Assumptions of this approach 
There were a number of assumptions employed in estimating the uncertainty illustrated 
above. The customer should appreciate these assumptions to allow for full and clear 
interpretation. Very generally, the assumptions are: 
1.   The blood alcohol measurement results are normally distributed 
2. All standard uncertainties are valid estimates  
3. The method uncertainty is probably over estimated due to some “double counting”  
4. The method of confidence interval estimation will be robust  
5. With a fixed mean (), 95% of the intervals will bracket  
6. The confidence interval expresses the uncertainty due to sampling variability only  
7. This entire approach to estimating the uncertainty is uncertain.  
8. We have assumed that all uncertainty components are independent  
We would not advocate that these assumptions be listed as part of the reported results. 
Rather, they should be available if requested by the end-user and toxicologists should be 
prepared to discuss them.  
5. Breath alcohol measurement example 
Our next example illustrates the uncertainty estimation for a breath alcohol measurement. 
We will assume the following measurement function which was presented earlier as 
equation 12: 
 
0 Sol
Corr
Cont
Y GC R
Y
X K GC
      (22)  
where: 0Y  the mean of the original n measurements 
SolGC   the mean of the simulator solution measurements by gas chromatography 
R   the traceable reference value  
www.intechopen.com
 
Toxicity and Drug Testing 430 
X   mean of the breath test instrument measuring the simulator solution heated to 340C 
K   1.23 the ratio of partition coefficients  
ContGC  the mean results from measuring the traceable controls on the gas 
chromatograph 
For this example we assume that simulator solutions are prepared and tested by gas 
chromatography within the toxicology laboratory. Commercially purchased standards 
(CRM) are used as calibrators and controls on the gas chromatograph. Certificates of 
analysis are used as Type B uncertainties to establish the traceability. For this example we 
will assume the following data are available for the six components of equation 22: 
Duplicate BrAC results: 0.081 and 0.085 g/210L, 0Y   0.0830 g/210L, :SolGC  mean = 0.0985 
g/dL u = 0.0007 g/dL n=15, R   0.100 g/dL u = 0.0003 g/dL, :X  mean = 0.0795 g/210L u 
= 0.0012 g/210L n=10, K  1.23 u = 0.012 and :ContGC  mean = 0.1015 g/dL u = 0.0006 g/dL 
n=28. We begin by computing the corrected mean BrAC results according to: 
   
   
0.0830 / 210 0.0985 / 0.100 /
0.0824 / 210
0.0795 / 210 1.23 0.1015 /
Corr
g L g dL g dL
Y g L
g L g dL
   
The estimate for the uncertainty in 0Y  will come from an uncertainty function seen in 
figure 6 and developed from a large number of duplicate breath alcohol tests using equation 
15. The total method uncertainty for our example determined from the linear model in 
figure 6 and using the corrected mean BrAC of 0.0824 g/210L is 0.0031 g/210L. Since our 
model in equation 22 is multiplicative we employ the RSS for the CV values and assume 
independence amongst all components. The combined uncertainty estimate is seen in 
equation 23. Next we estimate the 95% uncertainty interval and obtain: 
 
 0.0824 2 0.00239 0.0824 0.0048
0.0776 0.0872 / 210
CY k u Y U
to g L
      
 
Since the n for estimating the uncertainty function in figure 6 was very large, we assume 
an infinite degrees of freedom and use k=2 for estimating an approximate 95% confidence 
interval. Table 3 shows the uncertainty budget for this analysis. From the uncertainty 
budget we see that the total method accounted for the majority of the combined 
uncertainty (84%). This is not surprising since the breath sampling component, contained 
within the total method uncertainty function of figure 6, has significant variation. The 
budget also shows that the reference traceability, the GC measurement of the controls and 
the GC measurement of the simulator solution all provide 1% or less to the combined 
uncertainty. They could reasonably be ignored in this example. We now report our results 
as follows: 
The duplicate breath alcohol results were 0.081 and 0.085 g/210L with a corrected mean result of 
0.0824 g/210L. An expanded combined uncertainty of 0.0048g/210L assuming a coverage factor of 
k=2 with an infinite number of degrees-of-freedom and a normal distribution was generated from six 
principle components contributing to the uncertainty. An approximate 95% confidence interval for 
the true mean breath alcohol concentration is 0.0776 to 0.0872 g/210L.  
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 
 (23) 
The approximate 95% uncertainty interval estimated for this example shows that the lower 
limit falls below the critical legal driving level of 0.080 g/210L. We may be interested in 
knowing the probability that the true population mean BrAC is above 0.080 g/210L. This 
can be estimated by first considering our confidence interval in the following form: 
  (1- / 2) (1- / 2)Y YP Y - S     Y + S  = Z Z       (24) 
Since we are interested in determining the probability that µ exceeds the lower limit we 
rewrite equation 24 as follows:  
  (1- / 2) YP Y - S      = Z          (25) 
We set the lower limit expressed in equation 25 equal to 0.080 g/210L and solve for Z(1-ǂ/2):  
  24 0 00239 0 1.0(1- / 2) (1- / 2) (1- / 2)YY - S  = 0.080    0.08  - .  = .080     = Z Z Z     
 
 
Fig. 6. An uncertainty function plotting pooled standard deviation estimates against their 
concentration determined from a large number of duplicate breath alcohol results 
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Breath Alcohol
SD = 0.0260BrAC + 0.00095
n = 27,995 duplicates
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Source  Type Distribution Standard Uncertainty Percent1 
Total Method A Normal 0.0031 g/210L 84% 
GC Solution A Normal  0.0007 g/dL 0.5% 
Reference B  Normal 0.0003 g/dL 1% 
Breath Instrument A Normal 0.0012 g/210L 3% 
Simulator Part. Coef B Normal 0.012 11% 
GC Controls A Normal 0.0006 g/210L 0.5% 
Combined Uncertainty   0.00239 g/210L  
Expanded Uncertainty 
(k=2) 
  0.0048 g/210L  
95% confidence interval   0.0776 to 0. 0872 g/210L  
1 Percent of contribution to total combined uncertainty 
Table 3. Uncertainty budget for the illustrated breath alcohol example 
Next, we rearrange our probability statement, introduce the value for Z(1-ǂ/2), and refer to 
the standard normal tables:  
 1 /2 1.0 84131- / 2 1- / 2Y
Y
Y - 
P Y - S    = P   Z  = P Z   = P Z   = 0.Z Z
S
 
 
             
 
There is a probability of 0.8413 that the individual’s true mean BrAC exceeds 0.080 g/100ml. 
This may or may not rise to the level of proof beyond a reasonable doubt, depending on the 
opinion of the court. This example illustrated the use of simulator control standards 
produced within a local toxicology laboratory including their associated uncertainties. Some 
jurisdictions, however, choose to purchase simulator control standards rather than prepare 
their own. If that were the case in this example, we could have eliminated the GC solutions 
and GC controls from our uncertainty estimates. The simulator partition coefficient would 
have remained while the reference value would have been obtained from the certificate of 
analysis from the manufacturer and considered a Type B uncertainty. Therefore, rather than 
having to include the GC solution and GC control components separately in the combined 
uncertainty estimate, they should already be included within the manufacturer’s estimate of 
combined uncertainty, depending, of course, on how the solution standards were prepared 
and tested.  
6. Dealing with measurement bias 
Our principle objective here will be to illustrate several ways for treating uncorrected bias. 
Bias or systematic error is common in all measurements. Some consider different types of 
bias such as: (1) method bias, (2) laboratory bias and (3) run bias. (O’Donnell and Hibbert, 
2005) Not all, however, would agree with the need for classifications of bias. (Kadis, 2007, 
O’Donnell and Hibbert, 2007) Regardless of its classification or source, all forms of bias 
should ideally be determined and corrected for employing traceable control standards. As 
this is done, the uncertainty of that correction must be included as one of the components in 
the combined uncertainty. Occasionally, the analyst may determine that the bias is small 
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and insignificant and not correct for it. There are ways to handle uncorrected bias as well by 
adding an additional component to the combined uncertainty. We will consider some 
examples here. Estimations for bias can come from internal quality control, proficiency test 
data, collaborative studies or method validation data. (Kane, 1997)  
6.1 Preparing an alcohol in water control solution 
We will assume in this example that we desire to prepare an ethanol in water solution to be 
used as a control standard. We want to prepare this solution to have a concentration of 
approximately 0.10 g/dL. Our measurement function will be as follows: (Philipp et.al., 2010) 
 Etoh
Solution
m PD
C
m
   (26)  
where: C = the concentration of ethanol in water 
mEtoh = the mass measurement of ethanol 
P = the purity of the ethanol 
D = the density of the ethanol 
mSolution = the mass measurement of the combined solution of ethanol and water 
Preparing a control standard gravimetrically has advantages. (Gates, et.al., 2009) There is 
better traceability for the mass measurements and no concern regarding the uncertainty in 
volume measurements. We will assume the purity (P) to be 0.995 with a Type B standard 
uncertainty of 0.002 determined from the certificate of analysis. We further assume that the 
density (D) of the solution is 0.997 g/ml (OIML, King and Lawn, 1999) with a Type B 
standard uncertainty of 0.00054 g/ml (King and Lawn, 1999), determined from the 
certificate of analysis from the manufacturer of a density meter. For both the purity and the 
density we will assume the uniform distribution in order to estimate their standard 
uncertainties. The values for the density are obtained from published tables for 
ethanol/water solutions. The density of the solution will be a function of the mass fraction 
of ethanol. The higher the mass fraction of ethanol the closer the density will be to 0.789 
g/ml - the density of pure ethanol. The lower the mass fraction of ethanol the closer the 
density will be to 1.00 g/ml - the density of water. Since the density of the solution depends 
on the mass fraction of ethanol and we have selected a density of 0.997 g/ml (corresponding 
to a mass fraction of approximately 0.101%) and we desire a total solution mass of 1800 g, 
we need to have the mass of ethanol equal to 1.82 g. We will need to weigh 1.82 g of ethanol 
and place it into solution with water and add water until we have a total mass of 1800g. We 
will assume that the total solution mass is weighed on a scale that has had replicate 
measurements (n=30) of a 2 Kg traceable check weight (Type B uncertainty of 0.016 Kg) with 
a mean result of 1,940 g and a standard uncertainty of 30 g. This will be used to estimate the 
standard uncertainty in the measurement of Solutionm . We now recognize that there is a bias 
in the weighing of the total solution. The measured mass of the solution is low by 3.0%. This 
will affect the mass of the ethanol necessary to maintain the density of 0.997 and mass 
fraction of 0.101%. As a result the mass of the ethanol will need to be 1.87 g. The mass of 
ethanol was weighed on a different scale that also has a set of replicate measurements 
(n=23) of a 2.0 g traceable check weight (Type B standard uncertainty of 0.014g) with a mean 
result of 2.08 g and a standard uncertainty of 0.02g. This scale has a bias of +4.0%. We now 
incorporate our assumed measurement information into equation 26: 
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 (27)  
where: 
2KgR
X
 the correction factor for the bias in the scale used to weigh the total solution 
Notice that we only correct for the bias in the scale used to weigh the total solution but not for 
the scale used to weigh the ethanol. The question now is how to deal with the +4.0% bias in the 
one scale. We begin by estimating the combined uncertainty ignoring the bias (assuming it is 
zero) and assuming independence of all variables. Since equation 27 is a multiplicative model 
we employ the RSS of the CV’s squared as in equation 28. Notice that the standard uncertainty 
in the solution mass measurement comes from the repeatability measurements of the 2.0 Kg 
traceable check standards. There is no separate uncertainty estimate for the single 
measurement of the total solution of 1800 g. Employing the Welch-Sattherwaite equation to 
compute the effective degrees of freedom for our example we obtain: 
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 (28) 
The 95% confidence interval for our estimated concentration would be: 
  0.975,63 0.1000 2.00 0.00089 0.1000 0.00178 0.0982 0.1018cY t u to        
The next option for dealing with the bias in the mass measurement of the ethanol is to 
correct for it. This is always the recommended practice and consistent with the GUM 
document. Correcting the ethanol mass for the +4.0% bias yields a result of 1.80 g. Placing 
this corrected value into equation 27 yields a corrected concentration of 0.000962 g/ml or 
0.0962 g/dL. Now we must account for the uncertainty in the 2.0g reference check weight by 
including its Type B uncertainty in equation 28 where we add the additional term:
www.intechopen.com
 
Measurement Uncertainty in Forensic Toxicology: Its Estimation, Reporting and Interpretation 435 
2
2 2
2
0.014
1 1
2.00
gR
g
u
R
                  
 and, when including the corrected concentration, we obtain: 
 0.0986 0.0113 0.00111 /Cu g dL  . The uncertainty budget is shown in table 4 both when 
ignoring the bias and when including the bias correction. From table 4 we see that including 
the additional balance bias, the combined uncertainty increased by 25% and contributed 
38% to the combined uncertainty. The bias, in this example, is clearly significant and as a 
result should be corrected for. Before illustrating our next approach to handling uncorrected 
bias, we will evaluate the bias in our example to determine its significance. To do so we 
employ the following t-test:  
  
2 2 2 2
2.08 2.00
10.9
0.02 0.014
23 1
2.08 2.00
C R
C R
t
u u
   
                  
 (29)  
The critical value for a two-tailed test with 0.05   and effective degrees of freedom of 51 
from the t-distribution is 0.975,51 2.01t  . The results from equation 29 show the bias to be 
largely significant and should be corrected for. There are times when measurement bias is 
known to exist but is not corrected for. The analyst may believe the bias to be small and 
insignificant or it may be too complex to correct for. There are several methods that have 
been proposed for including the uncertainty due to uncorrected bias. (Maroto,et.al., 2002, 
Petersen, et.al., 2001) All of these effectively increase the expanded uncertainty by some 
amount to account for the uncorrected bias. Moreover, including an uncertainty component 
 
 Percent1
Source Type Standard 
Uncertainty
Ignoring Bias Correcting Bias 
Mass of Ethanol A  0.02 g 5% 3% 
Purity of Ethanol B 0.002 1% 1% 
Density of Solution B 0.00054 g/ml  1% 1% 
Mass of Solution A 30 g 12% 7% 
2.0 Kg Reference B  16 g 81% 50% 
2.0 g Reference  B 0.014 g  38% 
Combined Uncertainty   0.00089 g/dL 0.00111 g/dL 
1 Percent of contribution to total combined uncertainty 
Table 4. Uncertainty budget for the preparation of the control ethanol solution 
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resulting from a corrected bias is always less than the uncertainty component resulting from 
uncorrected bias. (Synek, 2005, Linsinger, 2008) One approach is to include the bias within 
the radical sign and estimate the expanded uncertainty (U) as follows: 
  
2
2 2 2 2 2 2
Etoh Sol Kgm P D m R
U kC CV CV CV CV CV bias       (30)  
Since all of the other terms within the radical sign are dimensionless relative variances, we 
must transform the bias into dimensionless relative units. Doing this with our example and 
assuming k=2 we obtain: 
 
  
2 2 2 2 22
0.02 0.002 0.00054 30 0.0816
23 3 3 30 2312 0.1000
2.08 0.995 0.997 1800 2000 2.00
2 0.1000 0.0122 0.0024 /
U
U g dL
                                                                 
 
 
The combined uncertainty with this approach is 0.00122 g/dL compared to 0.00111 g/dL 
when correcting for the bias and 0.00089 g/dL when ignoring the bias. Another approach is 
to incorporate the coverage factor k into the radical sign but without effecting the bias term 
as follows: 
  
2
2 2 2 2 2 2 2
Etoh Sol Kgm P D m R
U C k CV CV CV CV CV bias          (31) 
With this approach the combined uncertainty remains the same but the expanded 
uncertainty becomes 0.00196 g/dL. As expected, this is slightly less than the expanded 
uncertainty determined from equation 30 which was 0.0024 g/dL. A third approach is 
basically the same as correcting for the bias and is expressed as: 
     Y U bias y U bias Y y U bias          (32) 
For our example, the bias in the mass of the ethanol was +0.08g. The corrected mass of the 
ethanol should be 1.79 g rather than the 1.87 g value measured. Using the correct value of 
1.79 g, the corrected concentration of the ethanol should be 0.0957 g/dL. This indicates that 
we have a bias in the estimated concentration of +0.0043 g/dL. Using this value for our bias 
and assuming an approximate 95% confidence interval, equation 32 becomes: 
 
 
     0.1000 2 0.00089 0.0043 0.1000 2 0.00089 0.0043
0.0939 0.0975 /
Y
Y g dL
     
    
Notice that this interval is not symmetric around our estimated, yet biased, concentration of 
0.1000 g/dL. Instead, it has accounted for the +0.0043 g/dL bias and adjusted for this. 
The next proposal for handling uncorrected bias is to simply add the absolute value of the 
bias to the expanded uncertainty as: Y U bias  . For our example this would result in:  
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    0.1000 0.00608 0.1000 0.00608
0.0939 0.1061 /
Y U bias Y Y U bias Y
Y g dL
          
   
This clearly would yield the largest uncertainty interval compared to the preceding methods 
and is probably larger than necessary. The final method we will consider yields an 
expanded uncertainty interval that is also asymmetric about the measurement result. 
(Phillips, et.al., 1997) This method computes the confidence interval based on the expanded 
uncertainty (U) estimated as follows: 
 
0
:
0 0
0
0 0
c c
c
c c
c
Y U Y Y U
ku bias if ku bias
where U
if ku bias
ku bias if ku bias
and U
if ku bias
 


   
    
    
  (33) 
Using this approach for our example would yield:  
 0.1000 2 0.00089 0.0043 0.1000 0 0.0939 0.1000Y Y          .  
The asymmetry with this method has accounted for the positive bias and yields the same 
lower limit as the two preceding methods above. This results from the fact that our estimate 
is biased high by +0.0043 g/dL and was not corrected for. This last approach has more 
desirable statistical properties compared to the previous methods and has the advantage of 
avoiding negative expanded uncertainty limits (where the lower limit is below zero) which 
could occur at low concentrations. (Phillips, et.al., 1997)  
6.2 Estimating bias by recovery 
Another approach to estimating and handling bias is with recovery analysis. (Thompson, 
et.al., 1999) Recovery is the ratio, expressed as a percent, of the measurement result to the 
reference or true measurand value described by: 
 0
Re
% 100
f
C
R
C
     
 (34) 
where: %R = percent recovery 
C0 = the measured value 
CRef = the true value of the measurand 
Percent recovery is a metric more commonly applied in analytical contexts involving 
complex matrices with several steps of extraction, sample preparation and analysis of a 
specified sub-sample. The requirements of this complex procedure for extraction and 
analysis often results in a loss of the analyte prior to its actual quantitative determination. 
Hence, we have the concept of %Recovery. The accuracy of the analytical method is 
determined by its ability to quantify (recover) the full amount of the analyte in the original 
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matrix. Simply spiking alcohol in a blood sample and measuring it is not a typical 
application of percent recovery. The recovery is often determined during the method 
validation phase where a known blank matrix is spiked with a known mass of the relevant 
analyte. This is often referred to as a “reference recovery” or a “method recovery”. (Barwick 
and Ellison, 1999) When recovery estimates are applied to correct subsequent samples, it is 
very important that the concentrations and matrix are appropriately similar and that the 
same full analytical protocol is followed. Measurements of recovery from several spiked 
samples may be performed with the mean and standard deviation of the percent estimates 
determined, providing uncertainty estimates for the percent recovery in future 
measurements. The fractional recovery can be employed as a correction factor in the 
measurement equation as follows: 
  0Corr
C
C
R
   (35) 
where: CCorr = the corrected analytical result 
C0 = the original measurement 
R  the mean fractional recovery 
Assume that we are interested in determining the percent recovery of a specific drug for a 
particular analytical method. Assume that we have two vials of a subject’s blood, each 
containing 1.0 ml and each containing some unknown concentration of the drug of interest. 
To one tube we add 0.1ml of a known analyte standard having a concentration of 20mg/dL. 
We have now added a concentration of: 
20 0.1
1.82
0.1 1.0
mg ml mg
dL ml ml dL
    
. To the other tube 
we simply add 0.1 ml of water. We now measure the concentration of the analyte in each 
tube in replicate (at least twice) and determine the means to be: Tube with added analyte: 
10.8 mg/dL Tube with added water: 9.3 mg/dL. We now compute the percent recovery 
according to: 
 
10.8 / 9.3 /
%Recovery 100 100 82.4%
1.82 /
Measured Difference mg dL mg dL
Concentration Added mg dL
             
 (36) 
Assume that we have done this recovery experiment during method validation using blood 
specimens spiked with the analyte and obtained a mean % recovery of 84%R   with a 
standard uncertainty of 6% determined from 45 spiked samples. Assume further that we 
now have a suspect’s blood sample and we wish to provide an unbiased estimate of the 
analyte’s concentration using this recovery data. We determine the suspect’s sample results 
to be C0 = 15.4mg/dL with a standard uncertainty of 0.92mg/dL determined from n=56 
measurements of past quality control data. We further assume there are no other significant 
sources of bias, other than that estimated by the %Recovery. First we could determine 
whether the mean recovery of 84% was significantly different from 1.0 or not with the 
following t-test: 
  
1 0.84 1
17.9
0.06 / 45R
R
t
u
      (37) 
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The p-value for t = 17.9 with df=44 is <0.00001. We conclude that the mean recovery is very 
significantly different from 1.0. The recovery estimate should be used to correct the 
analytical results. Using our mean recovery to correct our analytical results yields: 
0 15.4 18.3 /
0.84
Corr
C
C mg dL
R
   . The combined uncertainty in our corrected estimate can 
now be determined from the RSS method using the CV’s squared since we have a 
multiplicative model and we assume independence according to:  
  
0
2 2
2 2
0.92 0.06
56 45 18.3 0.0126 0.231 /
18.3 18.3 0.84
C C
C R C
Corr
u u
CV CV u mg dL
C
                         
 
This results in a relative combined uncertainty of approximately 1.3%. Moreover, the 
analytical component contributed 45% while the recovery component contributed 65% to 
the combined uncertainty. The same analysis can be done when spiking blank specimens 
with a known concentration of the analyte. If we added the same 0.1ml of 20mg/dL 
concentration to 1.0ml of blank specimen, and quantified the specimen with our analytical 
method and obtained 1.65 mg/dL, this would become the numerator in equation 36 and we 
would obtain a recovery estimate of: 
 
1.65 /
%Recovery 100 100 90.7%
1.82 /
Measured Concentration mg dL
Concentration Added mg dL
             
.  
Both methods of spiking blank samples or spiking samples already containing the analyte 
are used in recovery studies. Moreover, it is important to remember with recovery studies 
the assumption that no other bias exists. We have briefly considered several ways that have 
been proposed to handle uncorrected bias. Ideally, bias should always be corrected for - 
even when statistically insignificant. When the bias is not corrected for, the combined 
uncertainty statement should include some additional component, thus increasing its 
magnitude, accounting for the uncorrected bias. Moreover, the customer should be made 
aware, either in the uncertainty statement or otherwise, when uncorrected bias exists and 
how it has been accounted for. 
7. Uncertainty in post-mortem drug analysis 
This example summarizes work recently published where methadone was measured in 
post-mortem cases. (Linnet, et.al., 2008) One sample of blood was taken from each femoral 
vein in 27 post-mortem autopsies. LC-MS/MS was the analytical method used to quantify 
both methadone and its main metabolite, 2-ethyl-1,5-dimethyl-3,3-diphenylpyrrolinium 
(EDDP). For our present example we will focus only on the quantitative measurement of 
methadone. While the study did not explicitly present a measurement function, the 
following would be a reasonable approximation: 
  
0
0
Meth
Cal
Corr
A A
m P
C
C C VC
C C
    (38) 
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where: CCorr = the corrected measurement of methadone 
C0 = the original quantitative measurement result of the methadone by LC-MS/MS 
CCal = the reference calibration and/or control value 
AC  the mean quantitative measurement of the reference value 
mMeth = mass of the reference methadone added to the calibration/control solution 
P = the purity of the methadone 
V = the volume of the calibration/control methadone solution 
The study also presented the following uncertainty estimates, expressed as %CV’s, for each 
of the components in equation 38: 3.65% 0.29% 0.53% 0.05%
MethA P m VC
u u u u    . 
The uncertainty in the purity was determined from employing the uniform distribution and 
the manufacturer’s certificate of analysis stating the purity was 99.99% ± 0.5%. The 
uncertainty in the original measurements (C0) was determined from the duplicate sampling, 
one from each femoral vein. The standard uncertainty for a single determination was 
determined from each of these results according to: 
 
 2 2
1 1
2 2
N N
ii
i i
M
rd d
u
N N
  
 
 (39) 
Equation 39, expressing the computation in two equivalent forms, was designed to estimate 
the total method (uM) component of uncertainty. A major part of this was due to the 
sampling technique from each of the femoral veins. This component was termed pre-
analytical (PA). Once the computations were determined from equation 39, the pre-
analytical component was determined according to: 
  
2 2 2
M PA ACV CV CV    (40) 
Finally, the combined uncertainty was determined according to: 
 2 2 2 2 2 2 2 2 2
MethT PA A Cal PA A m P V
CV CV CV CV CV CV CV CV CV         (41) 
Incorporating the uncertainty estimates outlined in Table 1 of the study we obtain: 
2 2 2 2 218.95% 3.65% 0.53% 0.29% 0.05% 19.3%TCV       . With this estimate we, and the 
authors of the study, have assumed independence of the components and a multiplicative 
measurement model. The uncertainty budget for this example is shown in Table 5, from 
which we see that the pre-analytical or sampling component contributes by far the most to 
the combined uncertainty. This is not unexpected since it represents the sampling 
component. Sampling, when included as a component in the combined uncertainty 
estimate, is typically the largest contributor. The study reported that amongst the 27 cases, 
the concentration of methadone ranged from 0.005 to 2.29 mg/kg with a median value of 
0.472 mg/kg. The median was appropriately reported, rather than the mean, because the 
distribution of results was positively skewed. Therefore, we would be interested in this case 
in computing a 95% confidence interval for the median. The most common approaches to 
estimating confidence intervals for a median do not involve uncertainty estimates. This 
results from the fact that the median is a quantile, specifically, the 50th percentile. One 
method for estimating the approximate 95% confidence interval for the median presented in 
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this study is to compute estimates of r and s as in equation 42. (Altman, et.al., 2000) For our 
sample size of n=27 and rounding the estimates to the nearest integer we obtain the results 
seen in equation 43. This would indicate that the 8th and 20th ordered observations would 
provide an approximate 95% confidence interval for the population median. The exact level 
of confidence for this example based on the binomial distribution would be 98.1%. (Altman, 
et.al., 2000)  
 
Source Type %CV Percent1 
Pre-Analytical A 18.95% 96% 
Analytical A 3.65% 3.9% 
Mass of Methadone A 0.53%  0.08% 
Purity B 0.29% 0.02% 
Volume B 0.05% 0% 
Combined Uncertainty  19.3% 100% 
1Percent of contribution to total combined uncertainty 
Table 5. Uncertainty budget for the post-mortem measurement of methadone in femoral 
blood  
  1 /2 1 /21
2 2 2 2
n n n n
r Z s Z  
                  
  (42) 
 
27 27 27 27
1.96 8.4 8 1 1.96 19.6 20
2 2 2 2
r s
                      
 (43) 
8. Uncertainty in a blood alcohol analysis 
The unique aspect of this example will be the addition of the uncertainty due to calibration. 
We will assume that duplicate blood alcohol results of 0.104 and 0.107 g/dL were obtained 
from the same headspace gas chromatograph. The following is our assumed measurement 
function: 
 0corr dilutor Calib
Cont
C R
C f f
X
    (44) 
where: Ccorr = the corrected BAC results 
C0 = the mean of the original measurement results 
R = the traceable reference control value 
ContX  the mean results from measuring the controls 
fdilutor = the correction factor for the dilutor 
 fCalib = the correction factor for the calibration 
We have added an additional correction factor  Calibf  in equation 44 which we also set 
equal to one and also include its uncertainty component. We will assume that the 
instrument was calibrated with a linear five point calibration curve generated by the use of 
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five traceable control standards. The calibration curve was generated by linear least squares 
yielding the following function: 
  Y a b X    (45) 
where: Y = instrument response, X = known control concentration values and a and b are 
model parameters. The objective in developing a calibration curve is to estimate the true 
value of a future unknown concentration (X) given some instrument response (Y). 
Therefore, we find the inverse of equation 45:  
 
Y a
X
b
 .  (46) 
For our purposes, we are interested in determining the uncertainty in X found in equation 
46. The parameters a and b, however, are correlated. We can eliminate the parameter a by 
solving for a according to a Y b X   and then substituting this into equation 46 according to: 
 
 0 0
0 0
Y Y b X Y Y
X X X
b b
       (47) 
where: X0 = a future single estimate of concentration 
Y0 = a future single instrument response 
Y  the mean of the instrument responses during calibration 
X  the mean of the control samples used during calibration 
From equation 47 we see that X0 is a function of only three random variables: Y0, Y , and b. 
Solving for the uncertainty in X0 by the method of error propagation we obtain: 
 
 
 0
2
0
22
1
1 1Y X
X n
i
i
S Y Y
u
b m n
b X X

  

 (48) 
where: SY|X = standard error from regression of Y on X in developing the calibration curve 
b = the slope of the calibration curve 
m = the number of measurements used to estimate X0 
n = the number of measurements used to generate the calibration curve  
We will assume specific values for the terms in equation 48 and solve for the uncertainty 
according to: 
 
 
 
   0
2
2
0.1055 0.15160.005 1 1
0.0042
1.02 2 5 1.02 0.046
Xu
     
Now, for our example we will assume the variables for equation 44 found in Table 6. For 
purposes of determining the uncertainties in each of the correction factors we assume 
Dilutorf  to be 10.65 and Calibf  to be 0.1058 g/dL. However, for estimating the corrected blood 
alcohol concentration in equation 44 we assume each to be 1.0. Next, we can estimate our 
corrected blood alcohol concentration according to: 
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  
 0
0.1055 0.100
1 1 0.1029 /
0.1025
corr dilutr Calib
C R
C f f g dL
X
      
  
We now combine the standard uncertainty components to determine the combined 
uncertainty according to equation 49. Estimating an approximate 95% uncertainty interval 
would yield: 
 0.1029 2 0.0020 0.1029 0.0040 0.0989 0.1069 /to g dL    .  
The percent contribution from each component to the combined uncertainty in this example 
is: C0 10%, R 2%, ContX  1% , Dilutorf  1% and Calibf  86%. From this we see that the calibration 
uncertainty contributed by far the most to the combined uncertainty. This may have 
resulted from the values assumed for this example and may not reflect most forensic 
programs. Each laboratory would need to determine this for their particular context. It 
should also be noted that equation 48 includes the uncertainty only of the least squares 
estimates and not that of the reference standards used as calibrants. These could be added as 
separate components. There are other methods to account for the uncertainty in calibration 
as well. For example, the maximum vertical deviation between the line of identify and the 
least squares regression line can be divided by the square root of three, assuming the 
uniform distribution, and  
 
Variable Estimate Uncertainty n 
C0 0.1055 0.0009 2 
R 0.100 0.0003 1  
ContX  0.1025 0.0008 16 
Dilutorf  10.65 0.05 10  
Calibf  0.1058 0.0042 5 
Table 6. The values of specific variables assumed for our blood alcohol measurement model 
 
0
2 22 22
0
2 2
0.00080.0009 0.0003
162 1
0.1029 0.1029 0.100 0.1
dilutor Calib
Corr
f fC R X
C
Corr dilutor Calib
C
u uu uu
u n n n n n
C R f fC X
u
                                                   
                    
 
2 2 2
0.050 0.0042
10 5
025 10.65 0.1058
0.1029 0.0192 0.0020 /
Y
u g dL
                               
 
 (49) 
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divided by the concentration value of X at that point. This is often termed a “lack of 
linearity” component.  
The preceding examples presented here have been illustrative only. There was no intention 
that the uncertainty estimates assumed were the only ones to be considered or even 
represented any specific laboratory program. They were presented simply to illustrate the 
computations involved. Indeed, there are surely other components to be considered. 
(Sklerov and Couper, 2011) These must be identified by the forensic toxicologist considering 
their particular laboratory, protocol, instruments, customers and the required fitness-for-
purpose.  
9. Different methods for estimating uncertainty 
We have illustrated above several examples for estimating the combined uncertainty in 
contexts relevant to forensic toxicology. These examples have presented the standard 
bottom-up approach recommended largely by the GUM document. There are, however, 
several other approaches to dealing with uncertainty that have been proposed in the 
forensic toxicology and metrological literature. Wallace, for example, has proposed a 
number of different methods for estimating measurement uncertainty. (Wallace, 2010) 
9.1 Use of proficiency test data 
One method advocated by Wallace is the use of proficiency test data. (Wallace, 2010) 
Proficiency testing basically consists of an organizing laboratory which, employing well 
established and traceable methods, prepares and tests the concentrations of several samples. 
These samples are then sent blindly to participating laboratories with instructions on how 
the measurements are to be performed, recorded and then returned to the organizing 
laboratory. The samples are to be treated by the participating laboratories as routine case 
samples and tested according to their routine protocols. The organizing laboratory 
summarizes the data reporting means, standard deviations and various plots, including, for 
example, Z-scores. The standard deviations at various mean concentrations can be used to 
generate uncertainty functions. Clearly, these estimates will exhibit rather large variation 
due to the different laboratories, instruments, protocols, analysts, time, etc. These estimates, 
conditioned on the appropriate concentration, can be used as the total method component in 
the combined uncertainty estimate. Consider an example where we have duplicate blood 
alcohol results obtained in the toxicology laboratory of 0.118 and 0.116 g/dL. The laboratory 
participated in a proficiency study which yielded the uncertainty function observed in 
figure 7. This figure was actually generated from data available from Collaborative Testing 
Services [CTS]. For this example we will assume the following measurement function: 
  0Corr
C R
C
X
  (50) 
where: CCorr = the corrected measurement result 
C0 = the mean of the original duplicate measurements 
R = the reference value for the controls  
X  the mean result for measuring the reference controls 
The mean of our assumed duplicate results is 0.1170 g/dL. The reference value is R=0.100 
g/dL with a Type B standard uncertainty of 0.0003 g/dL. The mean measurement of the 
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controls were 0.1024 /X g dL  with n=34 measurements and a standard uncertainty of 
0.0009 g/dL. Computing our corrected estimate from equation 56 we obtain 0.1143 g/dL. 
Using this value to estimate our method uncertainty from the equation found in figure 8 we 
obtain:  0.0369 0.1143 0.00129 0.0055 /Mu g dL   . Assuming independence and the 
multiplicative model of equation 50, we now estimate our combined uncertainty as seen in 
equation 51. The approximate 95% confidence interval (k=2) for the true mean blood alcohol 
concentration in this example would be:  
  2 0.1143 2 0.0039 0.1065 0.1221 /YY u to g dL    .  
The risk in using proficiency data in this manner is that the actual uncertainty associated 
with a particular laboratory may be overestimated. Another limitation to keep in mind is 
that the proficiency data may not have been generated with the same analytical protocol 
employed within a particular laboratory. Proficiency data, however, does have a large 
source of variation, which may be acceptable within the forensic context. The uncertainty 
budget for these results is found in Table 7. The method uncertainty determined from the 
proficiency test data in this example, contributed by far the most to the combined 
uncertainty while the reference and analytical components could effectively be ignored. 
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Fig. 7. Plot of the standard deviation against concentration and determination of an 
uncertainty function from CTS proficiency test blood alcohol data 
www.intechopen.com
 
Toxicity and Drug Testing 446 
 
 
0
0
2 22
2 2 2
0
22 2
0.00090.0055 0.0003
342 1 0.1143 0.0342 0.0039 /
0.1143 0.1143 0.100 0.1024
C R X
C C
C R X
Y
Y
u uu
u u n n nCV CV CV
C C C R X
u
u g dL
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                                 
(51) 
 
Source Type %CV Percent1 
Method (Proficiency) A 5% 99% 
Reference B 0.3%  0.8% 
Analytical A 0.9% 0.2% 
Total   100% 
1 Percent of contribution to total combined uncertainty 
Table 7. Uncertainty budget resulting from the use of proficiency test data as the estimate for 
method uncertainty  
9.2 Using the guard band approach 
Employing a guard band is another approach to accounting for measurement uncertainty. 
(EURACHEM/CITAC, 2000) Use of the guard band is a tool for determining compliance 
within specified limits. It establishes a decision rule, particularly relevant where there are 
critical or prohibited analytical limits which may define, for example, binary outcomes such 
as pass/fail, guilty/not guilty, etc. These can be important in drunk-driving prosecution 
where alcohol results (either blood or breath) are introduced to establish whether the subject 
exceeded the legal limit. Consider the example where an individual provided duplicate 
breath alcohol results of 0.092 and 0.098 g/210L. A traceable commercially purchased 
simulator control standard having a reference value of 0.0824 g/210L and a Type B 
combined uncertainty of 0.0008 g/210L was measured by the breath test instrument. The 
mean of n=46 measurements with this control was 0.0856 g/210L with a standard 
uncertainty of 0.0010 g/d10L. We wish to determine an upper limit to the guard band, 
above which we will be 99% confident that the individual’s true mean breath alcohol 
concentration exceeds 0.080 g/210L. This can be visualized in figure 8 where we see that the 
upper limit of the guard band is the value 0.080 + kuC. We must first find the combined 
uncertainty (uC) and then the appropriate value of k. The value of k will actually be from the 
t-distribution in this example and will need to correspond to a 98% confidence interval. The 
degrees of freedom will be determined from the Welch-Satterthwaite equation. We begin by 
identifying our measurement function as follows: 
 0Corr
C R
C
X
  (52) 
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where: CCorr = the corrected breath alcohol concentration 
R = the traceable control reference value 
X  the mean of replicate (n=18) measurements of the reference control standard  
 
 
Fig. 8. Illustrating the construction and use of a “guard band” to determine compliance with 
a specified limit  
The corrected mean breath alcohol results in our example is found from equation 52 to be: 
  
 
0.0950 0.0824
0.0914 / 210
0.0856
CorrC g L  . We will assume that our method uncertainty is 
determined from the uncertainty function found in figure 6 which results in: 
 0.0260 0.0914 0.00095 0.0033 / 210u g L   . Given that our measurement function in 
equation 52 is multiplicative, we now find our combined uncertainty, assuming 
independence, as in equation 51: 
  
22 2
0.00100.0033 0.0008
462 1 0.0914 0.0274 0.0025 / 210
0.0914 0.0914 0.0824 0.0856
Y
Y
u
u g L
                                 
.  
We now find the relative combined uncertainty by removing the values of n according to: 
 2 2 20.0033 0.0008 0.0010 0.0914 0.0391 0.0036 / 210
0.0914 0.0914 0.0824 0.0856
Y
Y
u
u g L
                     .  
Now we determine our effective degrees of freedom using the Welch-Satterthwaite equation 
as follows: 
4
4 4 4
0.0036
0.0914
5814.8
.0033 .0008 0.0010
0.0914 0.0824 0.0856
45
eff
      
                   
Notice that in the Welch-Satterthwaite equation we have changed our degrees of freedom 
for the total method component to infinity. This is because the standard uncertainty estimate 
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(0.0033 g/210L) from figure 6 is based on much more than one degree of freedom 
(n>27,000). The degrees of freedom for the reference standard in the Welch-Satterthwaite 
equation is set to infinity because it is a Type B uncertainty without information on the 
degrees of freedom provided. Since we have essentially an infinite number of effective 
degrees of freedom we select our k (or t) value of 1.96. We can now compute the upper limit 
for our guard band: 0.080 + 2.33(0.0025) = 0.0858 g/210L. Since the subject’s corrected mean 
breath alcohol concentration exceeds the upper guard band limit of 0.0858 g/210L we 
conclude there is 99% confidence that the individual’s true mean breath alcohol 
concentration exceeds 0.080 g/210L. Values exceeding 0.080 + kuc could be considered 
within the “rejection zone”. For a measurement in this region, the probability of a “false 
rejection” is less than ǂ, the probability of the false-positive error. (Desimoni and Brunetti, 
2007) One must also keep in mind that for guard band estimates at different concentrations, 
the combined uncertainty estimates need to incorporate the method uncertainty appropriate 
to that concentration. The guard band approach could also be generated based on a large set 
of historical data and then employed for a period of time. The estimates could be updated 
annually, for example, to ensure the system remains in statistical control. The assumptions 
with this approach is that the individuals continue to be tested on the same instrumentation 
and protocols used to generate the guard band limits and that the system remains in 
statistical control. The United Kingdom is one jurisdiction that employs a guard band 
approach. (Walls and Brownlee, 1985) A value of 6mg/dL is subtracted from the mean of 
duplicate blood alcohol results below 100 mg/dL and 6% is deducted from results over 100 
mg/dL. The results of this deduction must exceed their legal limit of 80 mg/dL for 
prosecution. Denmark employs a similar approach where they deduct 0.1 g/Kg to compute 
their level for prosecution. (Kristiansen and Petersen, 2004) Similarly, Sweden employs the 
guard band approach to uncertainty estimation by requiring that the lower 99.9% 
confidence interval limit for mean results must exceed their legal limit. (Jones and 
Schuberth, 1989) Guard band calculations could also be incorporated into computerized 
breath test instruments for immediate determination of critical limits for purposes of 
prosecution.  
9.3 Uncertainty estimation from total allowable error 
There is considerable debate regarding the best method for estimating measurement 
uncertainty and whether it is even necessary. Many argue that measurement uncertainty is 
unnecessary because it may be misunderstood by the customer or confuse the 
interpretation. Since bias is only determined with regard to a reference standard, many 
analytes do not have standards available while others have several. As a result, it is argued 
that bias may not be validly determined in the first place. Some that argue against the use of 
measurement uncertainty would advocate the use of total allowable error (TEa). (Westgard, 
2010) Total allowable error is determined from the following linear model:  
 a CTE bias k u  .  (53) 
The total allowable error combines both bias and random components and estimates the 
upper limit. In some cases this may over estimate the actual capability of the analytical 
method or laboratory performance. Moreover, the method of total allowable error does not 
correct for bias - it simply includes the maximum level allowable. If we were to allow a 
maximum bias of 4% and the relative combined uncertainty for the method was 2% and we 
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selected a coverage factor of k=2, we would obtain:  4% 2 2% 8%aTE    . This would 
provide an upper limit estimate for the customer who could be assured, with a high degree 
of probability, that the total error would not exceed this limit. One might report the final 
results in this context as: The whole blood alcohol results were 0.094 and 0.096 g/dL having a mean 
of 0.0950 g/dL which did not have an associated total allowable error of more than 8% with 
approximately 95% probability. One context appropriate for the application of the total error 
method is where a single control is measured as part of an analytical run. If the control 
exceeded the total allowable error, one would not know whether it was due to bias or 
random sources. However, the result would be caught and the system corrected before 
resuming routine measurements. One of the criticisms of the method of total allowable error 
method is that it allows bias to exist without correcting for it. (Dybkaer, 1999, Dybkaer, 
1999) Admittedly, the total error method provides a very conservative estimate, a maximum 
actually, for interpreting measurement uncertainty.  
9.4 Monte Carlo methods 
Monte Carlo methods are simulation techniques that are more computationally intensive. 
With faster computers available, these methods are becoming more popular. Monte Carlo 
methods require assumptions regarding the measurement function along with the 
distributional form and parameters for each of the input components, being themselves 
random variables. Random data are then simulated from each of the component 
distributions, placed into the measurement function, followed by the computation of the 
measurand. This is done a large number of times, generating a distribution of response 
values. From these results, the distribution, the expected value and the standard uncertainty 
of the response variable can be determined. As a result we do not need to assume some 
distributional form for the response variable and we have a direct, empirically determined 
estimate of uncertainty. Monte Carlo methods also avoid two limitations of the GUM 
method – the required linear relationship between the response variable and the 
components and the justified application of the central limit theorem. (Fernandez, et.al., 
2009) Consider the following example of a breath alcohol measurement function where we 
have six input variables: 
0 Sol
Corr
Cont
Y GC R
Y
X K GC
    and where we assume the following 
distributions for each of the six input variables:  20 ~ 0.1250,0.0047Y N  the mean of the 
original n measurements,  2~ 0.1025,0.0008SolGC N  the mean of the simulator solution 
measurements by gas chromatography,  2~ 0.100,0.0003R N the traceable reference value, 
 2~ 0.0825,0.0012X N  the mean of the breath test instrument measuring the simulator 
solution,  ~ 1.21,1.25K Unif  the ratio of partition coefficients in the simulator heated to 
340C and  2~ 0.0980,0.0008ContGC N  the results from measuring the traceable controls on 
the gas chromatograph. We employ a routine written in R that simulates random results 
from each of these distributions and computes the response variable  CorrY . This is done 
10,000 times. The resulting distribution for the response variable is seen in figure 9. The 
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expected value for the response variable is 0.1287 g/210L with an empirical 95% confidence 
interval of 0.1215 to 0.1360g/210L, determined from the distribution of results in figure 9. 
The sampling/method component was also correctly identified as having the largest 
contribution to total uncertainty of 85%.  
 
 
Fig. 9. A distribution of 10,000 Monte Carlo simulated measurement results  
10. Uncertainty in qualitative analysis 
Several measurements performed in forensic toxicology are qualitative in nature. These 
measurements typically take the form of a binary response (i.e., pass/fail, yes/no, 
over/under, present/absent, etc.). They are classification in nature where materials are 
assigned to discrete groups based on measurement results. Diagnostic tests are one 
important example of qualitative analyses. Their qualitative results are important indicators 
of whether some specified threshold has been exceeded or not and are important for the 
determination of further confirmatory analyses. In some cases the measurement system will 
respond simply with binary results (green light/red light). At other times the measurement 
system is quantitative on a continuous scale which can be dichotomized. For example, a pre-
arrest breath test instrument employing a fuel cell might measure the breath alcohol on a 
continuous concentration scale but is interpreted as being greater than or equal to 0.080 
g/210L or less than 0.080 g/210L. In either case, the response is considered binary and thus 
qualitative. The uncertainty associated with qualitative analyses has received much less 
attention than that of quantitative analysis. The uncertainty in qualitative analyses is 
basically probabilistic in nature - that is, we are interested in the probability of being correct 
in our decision. We are concerned primarily with the probability of false positive and false 
negative results. While there are a number of statistical methods for estimating the 
uncertainty associated with qualitative or diagnostic test results, there is no consensus as to 
which is to be preferred. (EURACHEM/CITAC, 2003, Pulido, et.al., 2003, Ellison, et.al., 
1998) Some methods involve the simple determination of false-positive (FP) and false-
negative (FN) fractions which in turn assess the probability of making a wrong decision. 
(Pepe, 2003) Other qualitative and quantitative methods employ Baye’s Theorem which is 
argued by many as a superior approach to estimating and interpreting measurement 
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uncertainty. (Gleser, 1998, Weise and Woger, 1992, Kacker and Jones, 2003, Phillips, et.al., 
1998). Space does not permit further discussion of these important and useful methods. 
11. Discussion 
Several examples have been presented here for estimating measurement uncertainty in the 
context of forensic toxicology. By no means do these examples imply that all possible 
uncertainty components have been considered. These examples were intended primarily to 
illustrate the general approach and computations involved. Moreover, while an example 
may have assumed a blood alcohol context, it could just as well have been applied in the 
context of breath or drug analysis. While the general approach will be relevant to most 
methods in forensic toxicology, each laboratory will need to identify and quantify its 
uncertainty components unique to its protocols and instrumentation. The examples and 
discussion presented here have also assumed independence among the input or predictor 
variables. This is certainly not always a valid assumption. In some measurement contexts 
there will be significant correlation between input variables which must be accounted for. 
(GUM, EURACHEM/CITAC, Ellison, 2005) While these concepts may be new to some 
practicing toxicologists, the concept of measurement uncertainty should not raise concerns 
for the forensic sciences. The emphasis should be on their ability to quantify confidence of 
measurement results. They should be presented in a manner that emphasizes and 
demonstrates their fitness-for-purpose. Modern technology should enhance and simplify 
these computations as well. Spreadsheet programs can be developed which require only the 
entry of specific values followed by the generation of all uncertainty results. Moreover, such 
computations can even be incorporated into the software of aalytical instruments. Such 
technology, when validated, should greatly simplify the process.  
Several factors are responsible for the emphasis today on reporting measurement results 
along with their uncertainty. These include legal, economic, liability, accrediting and 
technological considerations. As professional toxicologists concerned with providing 
measurement results of the highest possible quality, we must be prepared to make this extra 
effort of providing the relevant uncertainty. Since there is no consensus regarding the best 
approach for computing uncertainty at this time, toxicologists should be familiar with the 
several approaches suggested here and then select and validate the one which best suits 
their analytical, procedural and legal context. The literature is rich with material regarding 
measurement uncertainty and should be carefully reviewed by toxicologists. (Drosg, 2007, 
Williams, 2008, Fernandez, 2011 Ekberg,et.al., 2011) This effort wll enhance the quality and 
interpretability of our measurement results and help establish a foundation of “evidence 
based forensics”. The unavoidable fact of measurement uncertainty results in the risk of 
making incorrect decisions. While ignoring the uncertainty increases this risk, providing the 
uncertainty reduces and quantifies the risk for the decision maker. This fact alone should 
motivate the legal community to request and forensic toxicologists to rigorously estimate 
and provide such estimates. 
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